Phase I Vaccine Trial Shows Promise for Preventing Triple-Negative Breast Cancer

By News Health
44 minutes Ago

(MedPage Today) — At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA) vaccine designed to help prevent triple-negative breast cancer (TNBC), particularly among women at…

Source link : https://www.medpagetoday.com/meetingcoverage/sabcs-vp-earlybrca/118929

Author :

Publish date : 2025-12-10 15:26:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

COVID Vax Death Probe Expands; Eggs Recalled; Med School Enrollment Up

Real-World Outcomes Favor Standard Care in HER2-Positive Metastatic Breast Cancer

Semaglutide Tied to 50% Lower Risk for Epilepsy in Diabetes

What the evolution of tickling tells us about being human

Carfilzomib Improves Upon Bortezomib for Multiple Myeloma

Australia's social media ban faces challenges and criticism on day one